Buy NTLA stocks now with Interactive Brokers – the most advanced investment platform
- Performance
- Key stats
- Financials
- US politician trades
NTLA stock trades by the US Senators and Representatives
In the last 12 months Finbold has discovered a total of 0 NTLA trades made by 0 politicians. The the same period there was a total of 0 buy trades , and 0 sell trades . Based on this information, it appears that none of the total politicians preferred to buy Intellia Therapeutics, Inc stock, while none of the politicians preferred to sell Intellia Therapeutics, Inc stock.
The largest recorded NTLA stock trade by the US politician in the last 12 months was made by Thomas R. Carper , with a disclosed amount of between $1K - $15K .
NTLA stock does not seem to have any one politician who would have done more than one Intellia Therapeutics, Inc stock trade in the last 12 months.
Percentage
January 2025
Senator | Action | Amount | Date | Owner | Type |
---|---|---|---|---|---|
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
Unlock All Transactions As They Come
Upgrade now to access all U.S. politician trades for this and other stocks. Get the latest signals as they come.
September 2023
Name | Action | Traded at | Amount | |
---|---|---|---|---|
Thomas R. CarperSenator |
Sale |
August 25
September 5
|
$1K - $15K |
Signal Details
Thomas R. CarperSenator
Action
Sale
Traded at
August 25
Disclosed at
September 5
Amount
1K - $15K
Owner
Spouse
|
Methodology:
For trading activity of US Members of Congress, we collect data from the Financial Disclosures website. For US Senate trading activity, the data is collected from the United States Senate Financial Disclosures (eFD) website.
The price change since the date of disclosure is calculated by comparing the stock's closing price on the date of the disclosure to the current price of the asset.